XIUSHI

Xiushi Biopharma Co., Ltd. is a research and production enterprise specializing in protein engineering drugs, with synthetic biology technology at its core. It utilizes a proprietary multi-scale genetic component rational design platform to provide green, low-carbon, and efficient bio-manufacturing solutions. The core technical team of XIUSHI comprises doctors, university professors, and industry experts from the fields of synthetic biology, pharmaceuticals, and engineering, possessing extensive experience in drug development. The product pipeline features novel drugs, including recombinant proteins such as peptides, insulin analogs, and cytokines, as well as peptide-drug conjugates (PDC) and nanobodies (VHH).